University of Montana

ScholarWorks at University of Montana
University of Montana News Releases, 1928,
1956-present

University Relations

10-17-1966

University of Montana research may lead to new lifesaver
University of Montana--Missoula. Office of University Relations

Follow this and additional works at: https://scholarworks.umt.edu/newsreleases

Let us know how access to this document benefits you.
Recommended Citation
University of Montana--Missoula. Office of University Relations, "University of Montana research may lead
to new lifesaver" (1966). University of Montana News Releases, 1928, 1956-present. 2209.
https://scholarworks.umt.edu/newsreleases/2209

This News Article is brought to you for free and open access by the University Relations at ScholarWorks at
University of Montana. It has been accepted for inclusion in University of Montana News Releases, 1928,
1956-present by an authorized administrator of ScholarWorks at University of Montana. For more information,
please contact scholarworks@mso.umt.edu.

mmwm
FOR RELEASE

UNIVERSITY OF MONTANA
INFO RM ATIO N SERVICES

FROM

M ISSOULA. M ONTANA 59801
PHONE 243-2522
A R E A CODE 406

MONDAY, OCT, 17
UM RESEARCH MAY LEAD
TO NEW LIEESAVER

gidlund
10-14-66

Three million lives may be saved yearly as a result of tuberculosis research
being conducted at the University of Montana.
The Department of Health, Education and Welfare has announced Dr. Carl L. Larson,
UM professor of microbiology, has been awarded a conWAuing grant of $19*95^ for
his 1967 studies seeking the development of a "killed11 vaccine for the prevention
of tuberculosis.
The research is being conducted on a

cooperative basis with Dr. Edgar Ribi

of the Rocky Mountain Laboratory in Hamilton.

It began the Hamilton lab in 1955

when Dr. Larson was director of the facility.
Dr. Larson has been in charge of research at the Stella Duncan Memorial Institute
on the UM campus for the past four years.
He explained rabbits, guinea pigs and mice are subjects in experiments to find
a vaccine which will retain

Its effectiveness in field conditions.

The live microbes, which are used in current vaccines, frequently die when removed
from refrigeration for long periods and render the vaccine ineffective, he said.

Dr.

Larson also explained there is a possibility live vaccine could mutate into a virulant
strain of tuberculosis.
Tuberculosis has been virtually eliminated in the United States during the past
half century but 15 million new cases are reported worldwide yearly, largely in the
under-developed nations.

It is estimated three million deaths are attributed annually

to the disease.
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